Riskpilot← Back to searchSign inGet full accessSALFARM DANMARK A/S
A/SActiveCVR 67456211Nordager 19Wholesale of pharmaceutical and medical goods · NACE 4646Est. 198132 employeeswww.salfarm.com
Revenue 2025
DKK 68,1M
+15% vs 2024
EBITDA margin
71.5%
+19% vs 2024
Equity ratio
49.4%
Financial strength
Net profit 2025
DKK 37,1M
+19% vs 2024
| Revenue | DKK 68,1M | +15% |
| EBITDA | DKK 48,7M | +19% |
| Net profit | DKK 37,1M | +19% |
| Total assets | DKK 83,5M | +19% |
| Equity | DKK 41,3M | +0% |
| Employees | 32 | — |
Legal name
SALFARM DANMARK A/S
CVR number
67456211
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. december 1981
Share capital
DKK 1.000.000
Employees
32 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden og en direktør i forening eller af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er handel, produktion og forskning
Address
Nordager 19
Phone
+4575508080
Website
www.salfarm.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.641 | 11.871 | 15.897 | 16.417 | 19.183 | 21.725 | 23.762 | 26.892 | 36.633 | 44.717 | 44.006 | 46.107 | 59.122 | 68.137 |
| Staff expenses | -3.339 | -3.610 | -5.901 | -9.310 | -12.396 | -13.146 | -13.336 | -12.202 | -9.048 | -12.488 | -11.480 | -15.079 | -18.137 | -19.404 |
| EBITDA | 5.301 | 8.261 | 9.996 | 7.107 | 6.787 | 8.579 | 10.426 | 14.638 | 27.585 | 32.229 | 32.526 | 31.028 | 40.782 | 48.695 |
| Depreciation & amort. | -148 | -232 | -231 | -212 | -149 | -222 | -175 | -38 | -38 | -91 | -331 | -358 | -442 | -566 |
| EBIT | 5.153 | 8.029 | 9.765 | 6.895 | 6.638 | 8.357 | 10.252 | 14.601 | 27.547 | 32.138 | 32.195 | 30.670 | 40.340 | 48.129 |
| Net financials | 18 | 15 | -31 | 58 | -76 | 53 | -47 | 23 | -85 | -133 | -95 | -123 | -157 | -407 |
| Profit before tax | 5.171 | 8.044 | 9.734 | 6.953 | 6.562 | 8.410 | 10.205 | 14.624 | 27.463 | 32.005 | 32.099 | 30.547 | 40.182 | 47.722 |
| Tax | 1.341 | 2.062 | 2.435 | 1.644 | 1.504 | 1.917 | 2.337 | 3.284 | 6.103 | 7.018 | 7.125 | 6.803 | 8.936 | 10.618 |
| Net profit | 3.830 | 5.983 | 7.299 | 5.309 | 5.058 | 6.493 | 7.867 | 11.340 | 21.360 | 24.987 | 24.974 | 23.744 | 31.246 | 37.104 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 13.036 | 21.838 | 26.037 | 22.688 | 22.495 | 22.083 | 26.600 | 33.892 | 41.671 | 48.162 | 52.525 | 58.800 | 70.122 | 83.479 |
| Equity | 7.505 | 7.487 | 4.786 | 5.095 | 10.153 | 12.646 | 16.513 | 20.853 | 34.213 | 34.200 | 34.174 | 32.918 | 41.164 | 41.268 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 528 | 560 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5.308 | 14.128 | 21.034 | 17.401 | 12.135 | 9.244 | 9.916 | 12.350 | 6.737 | 13.962 | 18.300 | 25.695 | 28.458 | 41.231 |
| Total debt | 5.308 | 14.128 | 21.034 | 17.401 | 12.135 | 9.244 | 9.916 | 12.878 | 7.297 | 13.962 | 18.300 | 25.695 | 28.458 | 41.231 |
EBITDA margin
71.5%
This company
15.8%
Market median
+353% vs market
20122025
Equity ratio
49.4%
This company
38.2%
Market median
+29% vs market
20122025
Return on equity
89.9%
This company
18.4%
Market median
+389% vs market
20122025
Net profit margin
54.5%
This company
8.1%
Market median
+573% vs market
20122025
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
20122025
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CP Audit | Audit | 1981 | — | — |
PW Management | Management | 2008 | — | — |
RA Audit | Audit | 2008 | — | — |
MN Management | Management | 2008 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2014 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2009 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 1981 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2008 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
SALPHARM HOLDING ApS | Company | 100.0% | 100.0% | 2019 |
HNO HOLDING ApS | Company | 10.0% | 10.0% | 2002 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Salpharm Animal Health Holding A/SSalpharm Animal Health A/SSALPHARM HOLDING ApS
SALFARM DANMARK A/S (this company)Board members of SALFARM DANMARK A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Pihl | Audit | 0 companies |
| Peter Wendorff Olsen | Management | 0 companies |
| REVISIONPLUS A/S | Audit | 0 companies |
| Mette Nørgaard | Management | 0 companies |
| Sune Fraes Diernæs | Board of Directors | 0 companies |
| Mette Aabel Jensen | Board of Directors | 0 companies |
| Simon Damkjær Wille | Board of Directors | 0 companies |
| Ronnie Møller-Thorsøe | Board of Directors | 0 companies |
| Torben Bang | Chairman | 0 companies |
| Kristian Nørgaard Hansen | Board of Directors | 0 companies |
| Thomas Bjerregaard Thomsen | Chairman | 0 companies |
| Helmer Nørgaard Olsen | Chairman | 0 companies |
| Helene Wendorff Olsen | Board of Directors | 0 companies |
| Bodil Olsen | Board of Directors | 0 companies |
| Hans Peter Christian Olsen | Board of Directors | 0 companies |
| Michael Degn-Mortensen | Chairman | 0 companies |
| Karen Nørgaard Olsen | Board of Directors | 0 companies |